STOCK TITAN
  1. Home
  2. Sec-filings
  3. CL
  4. [Form 4] COLGATE PALMOLIVE CO Insider Trading Activity

Colgate-Palmolive (CL) director awarded shares and 2,424 stock options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Colgate-Palmolive director Lisa Edwards received routine equity awards as part of her compensation. She was granted 2,075 shares of common stock and 2,424 stock options on May 11, 2026 under the company’s incentive compensation plan. After the grant, she directly owns 18,182 common shares.

The options allow her to buy 2,424 common shares at an exercise price of $86.74 per share and expire on May 11, 2034. They become exercisable in equal annual installments over three years, starting on the first anniversary of the grant date.

Positive

  • None.

Negative

  • None.
Insider Edwards Lisa
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 2,424 $0.00 --
Grant/Award Common Stock 2,075 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 2,424 shares (Direct, null); Common Stock — 18,182 shares (Direct, null)
Footnotes (1)
  1. Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan. Annual director stock option grant under the issuer's incentive compensation plan. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.
Common stock grant 2,075 shares Annual director stock grant on May 11, 2026
Options granted 2,424 options Annual director stock option grant on May 11, 2026
Option exercise price $86.74/share Stock option strike price
Option expiration May 11, 2034 Stock option expiration date
Underlying option shares 2,424 shares Common shares underlying new options
Shares after grant 18,182 shares Total common shares directly held after transactions
Annual director stock grant financial
"Annual director stock grant under the issuer's incentive compensation plan"
incentive compensation plan financial
"under the issuer's incentive compensation plan, credited to a stock unit account"
An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.
stock unit account financial
"credited to a stock unit account pursuant to the issuer's incentive compensation plan"
stock option financial
"Annual director stock option grant under the issuer's incentive compensation plan"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercisable in equal annual installments financial
"Option becomes exercisable in equal annual installments over three years"
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Edwards Lisa
(Last)(First)(Middle)
C/O COLGATE-PALMOLIVE COMPANY
300 PARK AVENUE
(Street)
NEW YORK NEW YORK 10022
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/11/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/11/2026A(1)2,075A$0.000018,182D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$86.7405/11/2026A(2)2,424 (3)05/11/2034Common Stock2,424$0.00002,424D
Explanation of Responses:
1. Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan.
2. Annual director stock option grant under the issuer's incentive compensation plan.
3. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.
/s/ Kristine Hutchinson, Attorney-in-Fact05/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Colgate-Palmolive (CL) director Lisa Edwards report on this Form 4?

Lisa Edwards reported receiving equity compensation awards from Colgate-Palmolive. She was granted 2,075 shares of common stock and 2,424 stock options as part of the company’s incentive compensation plan, all dated May 11, 2026 and held as direct ownership.

How many Colgate-Palmolive (CL) shares does Lisa Edwards hold after this grant?

Following the grant, Lisa Edwards directly holds 18,182 Colgate-Palmolive common shares. This total reflects her position after receiving 2,075 new shares as an annual director stock grant under the company’s incentive compensation plan on May 11, 2026.

What are the terms of Lisa Edwards’ new Colgate-Palmolive (CL) stock options?

Lisa Edwards received 2,424 stock options with an exercise price of $86.74 per share. These options relate to Colgate-Palmolive common stock, expire on May 11, 2034, and were granted as part of the annual director stock option grant under the incentive compensation plan.

When do Lisa Edwards’ Colgate-Palmolive (CL) stock options become exercisable?

The stock options become exercisable in equal annual installments over three years. Vesting begins on the first anniversary of the May 11, 2026 grant date, meaning portions of the 2,424 options will vest each year during this three-year period.

Is Lisa Edwards’ Colgate-Palmolive (CL) Form 4 transaction a market purchase or sale?

The Form 4 shows compensation-related acquisitions, not market trades. Lisa Edwards received 2,075 shares and 2,424 stock options as annual director grants, reported with transaction code “A” for awards, with no open-market buying or selling indicated in this filing.